Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L.
American Journal of Epidemiology 157(11 Suppl): S11
2003
ISSN/ISBN: 0002-9262 Document Number: 276571
Document emailed within 1 workday
Related Documents
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
Hannaford, P.C. 2011: The progestogen content of combined oral contraceptives and venous thromboembolic risk Bmj 343: D6592
Herrero, R.; Brinton, L.A.; Reeves, W.C.; Brenes, M.M.; de Britton, R.C.; Tenorio, F.; Gaitan, E. 1990: Injectable contraceptives and risk of invasive cervical cancer: evidence of an association International Journal of Cancer 46(1): 5-7
Briggs, M.; Briggs, M. 1983: Oral contraceptives containing estrogen plus progestogen Benagiano, G And E Diczfalusy (Ed ) Comprehensive Endocrinology: Endocrine Mechanisms in Fertility Regulation Xi+354p Raven Press: New York, N Y , Usa Illus P17-48
Sandset, P.Morten. 2014: Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen Evidence-Based Medicine 19(5): 194
Balogun, O.R.; Raji, H.O. 2009: Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review Nigerian postgraduate medical journal 16(4): 260-263
Balogun, O.R.; Raji, H.O. 2009: Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review Nigerian postgraduate medical journal 16(4): 260-263
Sabra, A.; Bonnar, J. 1983: Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel Journal of Reproductive Medicine 28(1 Suppl): 85-91
Sheth, A.; Jain, U.; Sharma, S.; Adatia, A.; Patankar, S.; Andolsek, L.; Pretnar-Darovec, A.; Belsey, M.A.; Hall, P.E.; Parker, R.A.; Ayeni, S.; Pinol, A.; Li Hoi Foo, C. 1982: A randomized, double-blind study of two combined and two progestogen-only oral contraceptives Contraception 25(3): 243-252
Graham, C.A.; Ramos, R.; Bancroft, J.; Maglaya, C.; Farley, T.M. 1995: The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods Contraception 52(6): 363-369
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Schlesselman, J.J.; Stadel, B.V.; Murray, P.; Lai, S.H. 1987: Breast cancer risk in relation to type of estrogen contained in oral contraceptives Contraception 36(6): 595-613
Power, J.; Guillebaud, J. 2002: Long-acting progestogen contraceptives Practitioner 246(1634): 332; 335-341